The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

Raffaella Soldi(Translational Genomics Research Institute), Sunil Sharma(Translational Genomics Research Institute)
PLoS ONE
July 10, 2020
Cited by 82


Related Papers